Natural Alternatives International Inc
NAIIConsumer Defensive·Packaged Foods·USA·Nano·NASD·Nov 12 • 4:00 PM ET
Price
NAII against its 20, 50 and 200-day averages80.8% under the 52-week high of 4.96 on 13 Jan 2026. 52-week low 0.93 on 12 Nov 2026. Last 15 sessions, 31.2% high to low
Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average
Setup. RS line 0
CANSLIM 0 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50%; Average Volume: Over 200K — not on the tape: EPS Growth This Year: High (>25%)
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 0 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 0 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); Return on Equity: Over +15% — not on the tape: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%)
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 1 of 4 — fails: Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 1 of 4 — fails: Average Volume: Over 500K; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 1 of 4 — fails: Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 0 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200; Average Volume: Over 500K
Profile
NAIINatural Alternatives International, Inc. engages in the manufacturing, distribution, and marketing of nutritional supplements and other health care products. It operates through the Private-Label Contract Manufacturing, and Patent and Trademark Licensing segments. The Private-Label Contract Manufacturing segment provides manufacturing services to companies that market and distribute nutritional supplements and other health care products. The Patent and Trademark Licensing segment is involved in direct raw material sales and royalty income from license and supply agreements associated with the sale and use of beta-alanine. The company was founded by Mark A. LeDoux in 1980 and is headquartered in Carlsbad, CA.
| Employees | 230 |
|---|---|
| IPO | Jan 05, 1990 |
| Beta | 0.44 |
| ATR, 14d | 0.10 |
| Rel volume | 0.00 |
| Short float | 0.10% |
| Insider own | 17.90% |
| Inst own | 36.29% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | $5.96M |
| Enterprise Value | 48.46M |
| Income | -20.70M |
| Sales | 141.35M |
| Book / share | 7.97 |
| Cash / share | 1.19 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 230 |
| IPO | Jan 05, 1990 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 0.04 |
| Price / book | 0.12 |
| Price / cash | 0.80 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | 0.34 |
| Quick Ratio | 0.92 |
| Current Ratio | 1.73 |
| Debt / equity | 1.00 |
| Long-term debt / equity | 0.78 |
| Options and short | No / Yes |
Earnings
| Earnings / share | -3.42 |
|---|---|
| Earnings next year | - |
| Earnings next quarter | - |
| Earnings this year | - |
| Earnings next year | - |
| Earnings growth, 5 years | - |
| Past earnings growth | - - |
| Past sales growth | -3.44% -4.56% |
| Earnings vs last year | -52.59% |
| Sales vs last year | 9.08% |
| Earnings vs last quarter | -90.95% |
| Sales vs last quarter | 1.48% |
| Earnings | Sep 28 AMC |
| Surprise | - - |
Ownership
| Insiders own | 17.90% |
|---|---|
| Insider trades | 0.00% |
| Institutions own | 36.29% |
| Institution trades | 2.23% |
| Return on assets | -13.47% |
| Return on equity | -34.96% |
| Return on capital | -23.32% |
| Gross Margin | 5.54% |
| Operating margin | -6.41% |
| Profit Margin | -14.64% |
| 20-day average | -14.62% |
| 50-day average | -33.79% |
| 200-day average | -58.77% |
Technical
| Shares out | 6.27M |
|---|---|
| Shares floating | 5.15M |
| Short / float | 0.10% |
| Short ratio | 0.25 |
| Short interest | 0.01M |
| 52-week high | 4.96 -80.8% |
| 52-week low | 0.93 +2.3% |
| Volatility | 9.68% 6.12% |
| Average range | 0.10 |
| Strength index | 28.20 |
| Market sensitivity | 0.44 |
| Relative volume | 0.00 |
| Avg Volume | 21.56K |
| Volume | 0 |
Performance
| Perf Week | -15.13% |
|---|---|
| Perf Month | -16.62% |
| Perf Quarter | -53.41% |
| Perf Half Y | -64.79% |
| Perf YTD | -73.45% |
| Perf Year | -66.17% |
| Perf 3Y | -85.22% |
| Perf 5Y | -93.43% |
| Perf 10Y | -91.91% |
| Recommendation | - |
| Target Price | - |
| Prev Close | 0.95 |
| Price | 0.95 |
| Change % | 0.00% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| BHST | BioHarvest Sciences Inc | 36.95M |
| FTLF | FitLife Brands Inc | 77.95M |
| NATR | Nature's Sunshine Products Inc | 178.14M |
| LFVN | Lifevantage Corp | 63.92M |
| USNA | Usana Health Sciences Inc | 235.21M |
| MTEX | Mannatech Inc | 17.33M |
| HLF | Herbalife Ltd | 1.60B |
| PRE | Prenetics Global Limited | 283.20M |
| NHTC | Natural Health Trends Corp | 7.47M |
| BCPC | Balchem Corp | 5.48B |
Insider trading
14 filings| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| LEDOUX MARK A | CEO/Chairman | Mar 06 '26 | Buy | 2.80 | 532 | 1,490 | 160,221 | Mar 06 07:36 PM |
| LEDOUX MARK A | CEO/Chairman | Mar 04 '26 | Buy | 2.77 | 500 | 1,385 | 159,471 | Mar 06 07:36 PM |
| LEDOUX MARK A | CEO/Chairman | Mar 05 '26 | Buy | 2.75 | 218 | 600 | 159,689 | Mar 06 07:36 PM |
| LEDOUX MARK A | CEO/Chairman | Feb 27 '26 | Buy | 2.85 | 500 | 1,425 | 158,471 | Mar 03 07:23 PM |
| LEDOUX MARK A | CEO/Chairman | Mar 02 '26 | Buy | 2.79 | 500 | 1,395 | 158,971 | Mar 03 07:23 PM |
| LEDOUX MARK A | CEO/Chairman | Feb 26 '26 | Buy | 2.85 | 500 | 1,423 | 157,721 | Feb 27 05:18 PM |
| LEDOUX MARK A | CEO/Chairman | Feb 25 '26 | Buy | 2.81 | 500 | 1,405 | 157,221 | Feb 27 05:18 PM |
| LEDOUX MARK A | CEO/Chairman | Feb 27 '26 | Buy | 2.80 | 250 | 700 | 157,971 | Feb 27 05:18 PM |
| LEDOUX MARK A | CEO/Chairman | Feb 24 '26 | Buy | 2.71 | 1,000 | 2,710 | 156,971 | Feb 24 09:17 PM |
| LEDOUX MARK A | CEO/Chairman | Feb 23 '26 | Buy | 2.70 | 750 | 2,025 | 155,971 | Feb 24 09:17 PM |
| LEDOUX MARK A | CEO/Chairman | Feb 20 '26 | Buy | 2.65 | 250 | 664 | 155,221 | Feb 24 09:17 PM |
| LEDOUX MARK A | CEO/Chairman | Feb 17 '26 | Buy | 2.60 | 2,500 | 6,490 | 152,721 | Feb 20 06:05 PM |
| LEDOUX MARK A | CEO/Chairman | Feb 19 '26 | Buy | 2.56 | 1,500 | 3,833 | 154,721 | Feb 20 06:05 PM |
| LEDOUX MARK A | CEO/Chairman | Feb 18 '26 | Buy | 2.56 | 500 | 1,282 | 153,221 | Feb 20 06:05 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| DFSV | US Small Cap Value Portfolio ETF Class Shares | AUM: 8.56B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| DFMC | U.S. Micro Cap Portfolio ETF Class Shares | AUM: 213.58M |
| DFAS | U.S. Small Cap Portfolio-ETF Class Shares | AUM: 15.64B |
| BSVO | EA Bridgeway Omni Small-Cap Value ETF | AUM: 2.45B |
| DFAC | U.S. Core Equity 2 Portfolio-ETF Class Shares | AUM: 49.67B |
| DCOR | US Core Equity 1 Portfolio ETF Class Shares | AUM: 3.69B |
| BUSM | EA Bridgeway Ultra-Small Company Market ETF | AUM: 112.81M |
| DXUV | US Vector Equity Portfolio ETF Class Shares | AUM: 671.26M |
News
latest 14 of 200- Natural Alternatives: Fiscal Q4 Earnings Snapshot (Associated Press) -13.53%
- Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results (GlobeNewswire)
- Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results (GlobeNewswire)
- Natural Alternatives: Fiscal Q3 Earnings Snapshot (Associated Press)
- CarnoSyn Brands Expands TriBsyn Applications Across Beverage, Dairy, and Medical Nutrition (GlobeNewswire)
- Natural Alternatives Q2 Loss Widens Y/Y, Sales Increase (Zacks)
- Natural Alternatives: Fiscal Q2 Earnings Snapshot (Associated Press Finance) -26.79%
- Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results (GlobeNewswire)
- Niche Focus & Regulation Shape the Future of Healthcare Firms (Zacks)
- Natural Alternatives: Fiscal Q1 Earnings Snapshot (Associated Press Finance) +19.57%
- Natural Alternatives International, Inc. Announces 2026 Q1 Results (GlobeNewswire)
- Zacks Initiates Coverage of NAII With Neutral Recommendation (Zacks)
- Natural Alternatives Q4 Sales Rise 15% Y/Y, Loss Widens for FY25 (Zacks) -5.17%
- Natural Alternatives International, Inc. Announces Fiscal 2025 Q4 and YTD Results (GlobeNewswire)
Quarterly earnings
actual against estimate
No quarterly earnings.
Annual earnings
2010FY EPS 0.560. Sales 65.55
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2010FY | 0.560 | - | 0.580 | 65.55 | - | 1.70 |
Quarterly results
2026Q4 revenue 34.23, from 33.73 a year earlier. Operating margin -8.5%, from -1.7% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type.
No estimate revisions.
Estimate history
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | 0.73 | 0.922 | -0.246 | 1.688 | 1.74 | 0.429 | -1.229 | -2.283 | -3.433 |
| Sales USD millions | 130 | 137 | 116 | 179 | 168 | 157 | 114 | 130 | 141 |
| Shares million shares | 8 | 7 | 7 | 6 | 6 | 6 | 6 | 6 | 6 |
| Metric | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.317 | -0.335 | -0.37 | -0.368 | -1.168 | -0.048 | -0.425 | -0.716 | -2.23 |
| Sales USD millions | 29 | 33 | 34 | 29 | 34 | 37 | 35 | 35 | 34 |
| Shares million shares | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Income statement, annual
| Metric | TTM | 2026FY6/30/2026 | 2025FY6/30/2025 | 2024FY6/30/2024 | 2023FY6/30/2023 | 2022FY6/30/2022 | 2021FY6/30/2021 | 2020FY6/30/2020 | 2019FY6/30/2019 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 141.35 | 141.35+9.1% | 129.58+13.8% | 113.85-27.5% | 157.02-6.5% | 167.97-5.9% | 178.52+53.7% | 116.18-15.3% | 137.09 |
| Cost of Goods Sold Incl. D&A | 133.52 | 133.52+10.7% | 120.57+12.8% | 106.93-25.2% | 142.94-3.0% | 147.37-5.4% | 155.84+46.0% | 106.74-9.7% | 118.18 |
| Gross Profit | 7.83 | 7.83-13.1% | 9.01+30.2% | 6.92-50.9% | 14.09-31.6% | 20.59-9.2% | 22.68+140.3% | 9.44-50.1% | 18.91 |
| Selling, General and Administrative Excl. Other | 16.90 | 16.90+4.6% | 16.15+6.3% | 15.20+220.7% | 4.74-51.2% | 9.72+24.5% | 7.81-33.0% | 11.65-0.9% | 11.75 |
| Research and Development | - | 2.30+27.8% | 1.80-5.3% | 1.90-9.5% | 2.10-16.0% | 2.50+31.6% | 1.90+5.6% | 1.800.0% | 1.80 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 1.42 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -9.06 | -9.06 | -7.14 | -8.28-204.5% | 7.92-27.2% | 10.88-26.8% | 14.87 | -2.21-130.9% | 7.16 |
| Interest Expense | 1.19 | 1.19+29.3% | 0.92+155.6% | 0.36-20.0% | 0.45+462.5% | 0.08-33.3% | 0.12+71.4% | 0.07 | 0.00 |
| Unusual Expense | 10.85 | 10.85+502.8% | 1.80+800.0% | 0.200.0% | 0.200.0% | 0.20-83.3% | 1.20-40.0% | 2.00-16.7% | 2.40 |
| Net Income Before Taxes | -20.27 | -20.27 | -10.74 | -9.46-365.7% | 3.56-73.9% | 13.66+12.7% | 12.12 | -1.74-121.9% | 7.95 |
| Income Taxes | 0.43 | 0.43-84.8% | 2.83 | -2.25-318.4% | 1.03-65.1% | 2.95+116.9% | 1.36 | -0.09-106.4% | 1.41 |
| Consolidated Net Income | -20.70 | -20.70 | -13.57 | -7.22-386.5% | 2.52-76.5% | 10.71-0.6% | 10.77 | -1.65-125.2% | 6.54 |
| Net Income From Continuing Operations | -20.70 | -20.70 | -13.57 | -7.22-386.5% | 2.52-76.5% | 10.71-0.6% | 10.77 | -1.65-125.2% | 6.54 |
| Net Income | -20.70 | -20.70 | -13.57 | -7.22-386.5% | 2.52-76.5% | 10.71-0.6% | 10.77 | -1.65-125.2% | 6.54 |
| EPS (Recurring) per share | -2.16 | -2.17 | -2.07 | -1.21-368.9% | 0.45-74.4% | 1.76-3.3% | 1.82 | -0.04-103.4% | 1.16 |
| EPS (Basic, Before Extraordinaries) per share | -3.42 | -3.43 | -2.28 | -1.23-386.0% | 0.43-75.4% | 1.75+2.3% | 1.71 | -0.25-126.0% | 0.96 |
| EPS (Diluted) per share | -3.42 | -3.43 | -2.28 | -1.23-386.0% | 0.43-75.3% | 1.74+3.0% | 1.69 | -0.25-127.2% | 0.92 |
| EBITDA | -4.35 | -4.35 | -2.58 | -3.63-124.2% | 15.00-15.7% | 17.79-21.4% | 22.63+400.7% | 4.52-57.5% | 10.63 |
| Non-Operating Income (Expense) | 0.83 | 0.83 | -0.89 | -0.62 | -3.71-221.2% | 3.06 | -1.43-156.3% | 2.54-20.4% | 3.19 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 0.46 | 0.48-37.7% | 0.77-18.9% | 0.95+18.7% | 0.80+5.3% | 0.76-26.9% | 1.04-16.8% | 1.25-2.3% | 1.28 |
| Price To Earnings Ratio ratio statement ratio, not the snapshot | - | - | - | - | 16.97 | 5.99 | 10.02 | - | 8.58 |
| Price To Sales Ratio ratio | 0.10 | 0.10 | 0.15 | 0.31 | 0.27 | 0.38 | 0.60 | 0.39 | 0.60 |
| Gross Margin % | 5.54 | 5.54 | 6.95 | 6.08 | 8.97 | 12.26 | 12.71 | 8.13 | 13.79 |
| Operating Margin % | -6.41 | -6.41 | -5.51 | -7.27 | 5.04 | 6.48 | 8.33 | -1.90 | 5.22 |
| Net Margin % | -14.64 | -14.64 | -10.48 | -6.34 | 1.61 | 6.38 | 6.03 | -1.42 | 4.77 |
| Shares Outstanding million shares | 6.27 | 6.27+1.5% | 6.18-0.3% | 6.20+2.1% | 6.07-1.0% | 6.13-4.8% | 6.44-4.6% | 6.75-6.6% | 7.23 |
| Market Capitalization | 5.96 | 5.96-70.6% | 20.27-45.7% | 37.33-14.7% | 43.76-31.8% | 64.21-40.6% | 108.03+132.7% | 46.43-47.1% | 87.72 |
Income statement, quarterly
| Metric | 2026Q46/30/2026 | 2026Q33/31/2026 | 2026Q212/31/2025 | 2026Q19/30/2025 | 2025Q46/30/2025 | 2025Q33/31/2025 | 2025Q212/31/2024 | 2025Q19/30/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 34.23+1.5% | 35.30+23.1% | 34.50+1.6% | 37.33+12.4% | 33.73+14.4% | 28.68+14.3% | 33.97+34.1% | 33.21-2.1% |
| Cost of Goods Sold Incl. D&A | 32.78+8.1% | 35.10+30.3% | 32.30-0.3% | 33.33+7.9% | 30.33+8.1% | 26.94+16.1% | 32.41+30.6% | 30.89+0.2% |
| Gross Profit | 1.44-57.6% | 0.20-88.5% | 2.20+41.0% | 4.00+72.4% | 3.40+139.4% | 1.74-7.9% | 1.56+205.9% | 2.32-24.9% |
| Selling, General and Administrative Excl. Other | 4.35+9.3% | 4.30+9.4% | 4.24-2.5% | 4.01+2.8% | 3.98+1.0% | 3.93+4.2% | 4.35+12.4% | 3.90+8.0% |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -2.90 | -4.10 | -2.04 | -0.02 | -0.58 | -2.19 | -2.79 | -1.58 |
| Interest Expense | 0.47+123.8% | 0.27+8.0% | 0.22-21.4% | 0.23+27.8% | 0.21+75.0% | 0.25+257.1% | 0.28+300.0% | 0.18+100.0% |
| Unusual Expense | 10.55+603.3% | 0.10 | 0.100.0% | 0.10-50.0% | 1.50 | 0.00-100.0% | 0.10+233.3% | 0.20+185.7% |
| Net Income Before Taxes | -13.49 | -4.24 | -2.33 | -0.20 | -2.82 | -2.64 | -2.87 | -2.41 |
| Income Taxes | 0.05-98.9% | 0.07 | 0.22 | 0.09 | 4.40 | -0.46 | -0.68 | -0.43 |
| Consolidated Net Income | -13.54 | -4.31 | -2.55 | -0.29 | -7.22 | -2.19 | -2.19 | -1.98 |
| Net Income From Continuing Operations | -13.54 | -4.31 | -2.55 | -0.29 | -7.22 | -2.19 | -2.19 | -1.98 |
| Net Income | -13.54 | -4.31 | -2.55 | -0.29 | -7.22 | -2.19 | -2.19 | -1.98 |
| EPS (Recurring) per share | -1.01 | -0.70 | -0.41 | -0.04 | -1.00 | -0.37 | -0.36 | -0.31 |
| EPS (Basic, Before Extraordinaries) per share | -2.23 | -0.72 | -0.42 | -0.05 | -1.17 | -0.37 | -0.37 | -0.33 |
| EPS (Diluted) per share | -2.23 | -0.72 | -0.42 | -0.05 | -1.17 | -0.37 | -0.37 | -0.33 |
| EBITDA | -1.72-396.6% | -2.90 | -0.87 | 1.15 | 0.58 | -1.09 | -1.65 | -0.45-172.6% |
| Non-Operating Income (Expense) | 0.43 | 0.23 | 0.03-90.0% | 0.14 | -0.52 | -0.20-322.2% | 0.30 | -0.46 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 0.08-42.9% | 0.08-50.0% | 0.16-46.7% | 0.14-41.7% | 0.14-41.7% | 0.16-46.7% | 0.300.0% | 0.24-20.0% |
| Price To Sales Ratio ratio | 0.10 | 0.11 | 0.16 | 0.13 | 0.16 | 0.16 | 0.21 | 0.30 |
| Gross Margin % | 4.22 | 0.56 | 6.38 | 10.70 | 10.07 | 6.05 | 4.60 | 6.98 |
| Operating Margin % | -8.49 | -11.62 | -5.91 | -0.05 | -1.73 | -7.64 | -8.20 | -4.75 |
| Net Margin % | -39.56 | -12.21 | -7.40 | -0.78 | -21.40 | -7.62 | -6.45 | -5.97 |
| Shares Outstanding million shares | 6.27+1.5% | 6.28+1.6% | 6.18-0.3% | 6.18-0.3% | 6.18-0.3% | 6.18-0.3% | 6.20+1.8% | 6.20+1.8% |
| Market Capitalization | 5.96-70.6% | 16.24-23.8% | 22.11-17.3% | 17.63-50.4% | 20.27-45.7% | 21.32-42.5% | 26.72-32.8% | 35.53-9.9% |
Balance sheet, annual
| Metric | 2026FY6/30/2026 | 2025FY6/30/2025 | 2024FY6/30/2024 | 2023FY6/30/2023 | 2022FY6/30/2022 | 2021FY6/30/2021 | 2020FY6/30/2020 | 2019FY6/30/2019 | 2018FY6/30/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 7.47-39.4% | 12.32+2.8% | 11.98-11.9% | 13.60-37.7% | 21.83-32.1% | 32.13+5.4% | 30.48+21.7% | 25.04+6.1% | 23.61 |
| Short Term Receivables | 20.65+38.4% | 14.92-11.7% | 16.89+130.4% | 7.33-58.1% | 17.49-8.1% | 19.04+6.7% | 17.85+5.9% | 16.86+4.6% | 16.12 |
| Inventories | 30.75+23.6% | 24.87+2.6% | 24.25-18.3% | 29.69-8.6% | 32.48+20.3% | 27.01-3.4% | 27.97+7.6% | 26.00+10.3% | 23.57 |
| Other Current Assets | 6.56-8.4% | 7.16-15.7% | 8.49+33.1% | 6.38+28.9% | 4.95+128.1% | 2.17-20.5% | 2.73-21.6% | 3.48+85.1% | 1.88 |
| Total Current Assets | 65.43+10.4% | 59.28-3.8% | 61.61+8.1% | 57.01-25.7% | 76.75-4.5% | 80.35+1.7% | 79.02+10.7% | 71.39+9.5% | 65.18 |
| Net Property, Plant & Equipment | 59.67-35.1% | 91.94-4.0% | 95.75+29.0% | 74.21+12.0% | 66.27+73.7% | 38.15-4.3% | 39.88+89.1% | 21.09+9.3% | 19.29 |
| Total Investments and Advances | 0.00 | 0.00-100.0% | 0.08 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.31 | 0.00 |
| Deferred Tax Assets | 14.57+1.5% | 14.35+14.3% | 12.56+3488.6% | 0.35 | 0.00-100.0% | 0.21+5.0% | 0.20-89.0% | 1.82+37.9% | 1.32 |
| Other Assets | 1.34+86.1% | 0.72-58.6% | 1.74-32.6% | 2.58-13.4% | 2.98+89.8% | 1.57+41.4% | 1.11+56.3% | 0.71-2.7% | 0.73 |
| Total Assets | 141.02-15.2% | 166.29-3.2% | 171.74+28.0% | 134.15-8.1% | 146.00+21.4% | 120.28+0.1% | 120.20+26.1% | 95.31+10.1% | 86.53 |
| Short Term Debt Incl. Current Port. of LT Debt | 11.20+152.8% | 4.43-9.4% | 4.89+77.2% | 2.76+820.0% | 0.30 | 0.00-100.0% | 10.00 | 0.00 | 0.00 |
| Accounts Payable | 18.15+18.2% | 15.35+20.5% | 12.74+63.8% | 7.78-51.9% | 16.18+36.1% | 11.89-5.0% | 12.51+45.0% | 8.63-10.6% | 9.65 |
| Income Tax Payable | - | 0.41-19.6% | 0.51+37.8% | 0.37+117.6% | 0.17-72.6% | 0.62-38.6% | 1.01-17.2% | 1.22+54.4% | 0.79 |
| Other Current Liabilities | 8.37-2.8% | 8.61+61.5% | 5.33+7.2% | 4.97-24.7% | 6.60-31.0% | 9.56+122.8% | 4.29-2.5% | 4.40+14.6% | 3.84 |
| Total Current Liabilities | 37.72+31.0% | 28.80+22.8% | 23.46+47.7% | 15.88-31.7% | 23.26+5.4% | 22.07-20.6% | 27.81+95.2% | 14.25-0.2% | 14.28 |
| Long Term Debt | 38.77-29.0% | 54.60-1.4% | 55.40+96.7% | 28.17-10.7% | 31.54+91.4% | 16.48-12.2% | 18.78 | 0.00 | 0.00 |
| Provision for Risks Charges | 0.00-100.0% | 0.11-21.4% | 0.14-58.8% | 0.340.0% | 0.34-12.8% | 0.39-44.3% | 0.70+180.0% | 0.25+525.0% | 0.04 |
| Deferred Tax Liabilities | 14.57+1.5% | 14.35+52.8% | 9.39 | - | 1.22 | - | - | 2.83+52.2% | 1.86 |
| Other Liabilities | 0.00 | 0.00-100.0% | 0.74-25.3% | 0.99-11.6% | 1.12-10.4% | 1.25-18.8% | 1.54-18.5% | 1.89-10.0% | 2.10 |
| Total Liabilities | 91.06-6.9% | 97.86+9.8% | 89.14+96.4% | 45.38-21.1% | 57.48+43.0% | 40.20-17.7% | 48.83+154.1% | 19.22+5.1% | 18.28 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 49.96-27.0% | 68.43-17.1% | 82.59-7.0% | 88.77+0.3% | 88.52+10.5% | 80.08+12.2% | 71.38-6.2% | 76.08+11.5% | 68.25 |
| Total Shareholders Equity | 49.96-27.0% | 68.43-17.1% | 82.59-7.0% | 88.77+0.3% | 88.52+10.5% | 80.08+12.2% | 71.38-6.2% | 76.08+11.5% | 68.25 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 49.96-27.0% | 68.43-17.1% | 82.59-7.0% | 88.77+0.3% | 88.52+10.5% | 80.08+12.2% | 71.38-6.2% | 76.08+11.5% | 68.25 |
| Total Liabilities & Stockholders Equity | 141.02-15.2% | 166.29-3.2% | 171.74+28.0% | 134.15-8.1% | 146.00+21.4% | 120.28+0.1% | 120.20+26.1% | 95.31+10.1% | 86.53 |
| Book Value Per Share per share | 7.97-28.1% | 11.08-16.8% | 13.32-8.9% | 14.62+1.2% | 14.44+16.1% | 12.44+17.7% | 10.57+0.4% | 10.53+16.6% | 9.03 |
| Tangible Book Value Per Share per share | 7.97-28.1% | 11.08-16.8% | 13.32-8.9% | 14.62+1.2% | 14.44+16.1% | 12.44+17.7% | 10.57+0.4% | 10.53+16.6% | 9.03 |
| Full-Time Employees people | 230-1.7% | 234-24.5% | 310+28.6% | 241-18.0% | 294+28.9% | 228+23.9% | 184-1.1% | 186-24.4% | 246 |
| Price to Book Ratio ratio | 0.12 | 0.26 | 0.44 | 0.49 | 0.72 | 1.35 | 0.65 | 1.10 | 1.22 |
| Return on Assets % | -13.47 | -8.03 | -4.72 | 1.80 | 8.05 | 8.96 | -1.53 | 7.19 | 6.35 |
| Return on Equity % | -34.96 | -17.98 | -8.42 | 2.85 | 12.71 | 14.22 | -2.23 | 9.06 | 7.81 |
| Return on Invested Capital % | -23.32 | -11.03 | -5.23 | 2.16 | 8.92 | 11.15 | -1.82 | 8.60 | 7.40 |
| Quick Ratio ratio | 0.92 | 1.19 | 1.59 | 1.72 | 1.90 | 2.42 | 1.84 | 3.18 | 2.91 |
| Current Ratio ratio | 1.73 | 2.06 | 2.63 | 3.59 | 3.30 | 3.64 | 2.84 | 5.01 | 4.56 |
Cash flow, annual
| Metric | TTM | 2026FY6/30/2026 | 2025FY6/30/2025 | 2024FY6/30/2024 | 2023FY6/30/2023 | 2022FY6/30/2022 | 2021FY6/30/2021 | 2020FY6/30/2020 | 2019FY6/30/2019 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -20.70 | -20.70 | -13.57 | -7.22-386.5% | 2.52-76.5% | 10.71-0.6% | 10.77 | -1.65-125.2% | 6.54 |
| Depreciation | 4.71 | 4.71+3.3% | 4.56-1.9% | 4.65-34.3% | 7.08+2.5% | 6.91-11.0% | 7.76+15.3% | 6.73+94.5% | 3.46 |
| Other Funds (Non Cash) | 16.25 | 16.25+66.5% | 9.76+33.2% | 7.33 | -0.38-141.3% | 0.92-34.8% | 1.41-72.5% | 5.13+175.8% | 1.86 |
| Funds from Operations | 0.27 | 0.27-93.8% | 4.36+135.7% | 1.85-77.6% | 8.25-57.3% | 19.30-2.2% | 19.73+111.7% | 9.32-22.8% | 12.08 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -9.19 | -9.19-685.4% | 1.57 | -3.35 | -1.23 | -7.43-788.0% | 1.08 | -5.63 | -5.52 |
| Income Taxes Payable | -0.14 | -0.14 | -1.11-684.2% | 0.19 | -0.17-137.8% | 0.45 | -0.74 | -0.16 | -0.67 |
| Cash from Operating Activities | -8.92 | -8.92-250.4% | 5.93 | -1.50-121.4% | 7.02-40.9% | 11.87-43.0% | 20.81+464.0% | 3.69-43.8% | 6.56 |
| Capital Expenditures | -3.70 | -3.70 | -3.61 | -3.02 | -13.52 | -26.49 | -5.11 | -4.54 | -5.33 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.06+100.0% | 0.03-57.1% | 0.07+75.0% | 0.04+100.0% | 0.02 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 1.50 |
| Cash from Investing Activities | -3.70 | -3.70 | -3.61 | -3.02 | -13.47 | -26.46 | -5.04 | -4.51 | -3.81 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | -0.09 | -0.09 | -0.18 | -0.22 | -1.50 | -5.50 | -4.11 | -3.75 | -1.33 |
| Repurchase of Common Pref Stock | -0.09 | -0.09 | -0.18 | -0.22 | -1.50 | -5.50 | -4.15 | -3.75 | -1.37 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.04 | 0.00-100.0% | 0.04 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.04 |
| Issuance or Reduction of Debt, Net | 7.86 | 7.86 | -1.80-157.9% | 3.11 | -0.28-102.9% | 9.79 | -10.00-200.0% | 10.00 | 0.00 |
| Change in Long Term Debt | 2.01 | 2.01 | -0.30 | -0.29 | -0.28-102.9% | 9.79 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 11.00 | 11.00 | 0.00 | 0.00 | 0.00-100.0% | 10.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -8.99 | -8.99 | -0.30 | -0.29 | -0.28 | -0.20 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 7.77 | 7.77 | -1.97-168.2% | 2.89 | -1.78-141.5% | 4.29 | -14.11-325.8% | 6.25 | -1.33 |
| Net Change in Cash | -4.85 | -4.85-1526.5% | 0.34 | -1.62 | -8.23 | -10.30-720.5% | 1.66-69.5% | 5.44+280.4% | 1.43 |
| Free Cash Flow | -12.62 | -12.62-644.0% | 2.32 | -4.51 | -6.50 | -14.62-193.1% | 15.70 | -0.85-168.5% | 1.24 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow ratio | - | - | 8.41 | - | - | - | 6.84 | - | 66.90 |
| Deferred Taxes & Investment Tax Credit | - | 0.00-100.0% | 3.61 | -2.91 | -0.97-229.3% | 0.75 | -0.21 | -0.89-523.8% | 0.21 |
Balance sheet, quarterly
| Metric | 2026Q46/30/2026 | 2026Q33/31/2026 | 2026Q212/31/2025 | 2026Q19/30/2025 | 2025Q46/30/2025 | 2025Q33/31/2025 | 2025Q212/31/2024 | 2025Q19/30/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 7.47-39.4% | 9.20-13.3% | 3.75-56.7% | 7.74-23.8% | 12.32+2.8% | 10.61-14.5% | 8.66-47.8% | 10.16-39.3% |
| Short Term Receivables | 20.65+38.4% | 20.66+58.8% | 17.88+0.3% | 19.10+8.4% | 14.92-11.7% | 13.01+1.0% | 17.82+57.1% | 17.62+74.6% |
| Inventories | 30.75+23.6% | 29.93+10.9% | 33.43+45.1% | 30.65+18.2% | 24.87+2.6% | 26.99+28.1% | 23.04+17.6% | 25.93+11.3% |
| Other Current Assets | 6.56-8.4% | 4.21-46.8% | 6.45-28.6% | 7.56-13.9% | 7.16-15.7% | 7.91-1.1% | 9.03+31.6% | 8.78+15.4% |
| Total Current Assets | 65.43+10.4% | 63.99+9.3% | 61.52+5.1% | 65.05+4.1% | 59.28-3.8% | 58.52+7.7% | 58.55+7.6% | 62.48+8.2% |
| Net Property, Plant & Equipment | 59.67-35.1% | 89.94-2.5% | 91.04-2.4% | 91.21-2.9% | 91.94-4.0% | 92.25-4.3% | 93.24-5.1% | 93.98-5.7% |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% |
| Deferred Tax Assets | 14.57+1.5% | - | - | - | 14.35+14.3% | 3.24+1017.2% | 3.12+875.0% | 3.33+1981.3% |
| Other Assets | 1.34+86.1% | 0.940.0% | 0.75-38.0% | 0.69-53.4% | 0.72-58.6% | 0.94-51.0% | 1.21-51.6% | 1.48-34.8% |
| Total Assets | 141.02-15.2% | 154.880.0% | 153.30-1.8% | 156.94-2.7% | 166.29-3.2% | 154.94+1.1% | 156.13+0.3% | 161.27+0.6% |
| Short Term Debt Incl. Current Port. of LT Debt | 11.20+152.8% | 12.67+193.3% | 8.44+16.7% | 5.03-34.3% | 4.43-9.4% | 4.32+202.1% | 7.23+375.7% | 7.66+439.4% |
| Accounts Payable | 18.15+18.2% | 18.16+41.7% | 16.55+92.4% | 20.09+101.9% | 15.35+20.5% | 12.82+83.9% | 8.60+14.8% | 9.95+30.7% |
| Income Tax Payable | - | 0.00 | 0.00 | 0.00-100.0% | 0.41-19.6% | 0.00 | 0.00 | 0.09-55.0% |
| Other Current Liabilities | 8.37-2.8% | 8.30+34.5% | 7.87+35.2% | 8.78+30.3% | 8.61+61.5% | 6.17+17.5% | 5.82+32.3% | 6.74+8.5% |
| Total Current Liabilities | 37.72+31.0% | 39.12+67.8% | 32.85+51.7% | 33.90+38.8% | 28.80+22.8% | 23.31+70.8% | 21.65+61.4% | 24.43+58.2% |
| Long Term Debt | 38.77-29.0% | 52.50-3.0% | 53.27-2.1% | 53.90-3.4% | 54.60-1.4% | 54.11-0.6% | 54.44-2.4% | 55.77+1.5% |
| Provision for Risks Charges | 0.00-100.0% | 0.15-6.3% | 0.14-12.5% | 0.12-14.3% | 0.11-21.4% | 0.16-44.8% | 0.16-54.3% | 0.14-57.6% |
| Deferred Tax Liabilities | 14.57+1.5% | - | - | - | 14.35+52.8% | - | - | - |
| Other Liabilities | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 0.740.0% | 0.740.0% | 0.740.0% |
| Total Liabilities | 91.06-6.9% | 91.77+17.2% | 86.25+12.0% | 87.92+8.4% | 97.86+9.8% | 78.33+13.3% | 76.99+9.5% | 81.08+13.5% |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 49.96-27.0% | 63.11-17.6% | 67.05-15.3% | 69.02-13.9% | 68.43-17.1% | 76.62-8.9% | 79.14-7.4% | 80.19-9.7% |
| Total Shareholders Equity | 49.96-27.0% | 63.11-17.6% | 67.05-15.3% | 69.02-13.9% | 68.43-17.1% | 76.62-8.9% | 79.14-7.4% | 80.19-9.7% |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 49.96-27.0% | 63.11-17.6% | 67.05-15.3% | 69.02-13.9% | 68.43-17.1% | 76.62-8.9% | 79.14-7.4% | 80.19-9.7% |
| Total Liabilities & Stockholders Equity | 141.02-15.2% | 154.880.0% | 153.30-1.8% | 156.94-2.7% | 166.29-3.2% | 154.94+1.1% | 156.13+0.3% | 161.27+0.6% |
| Book Value Per Share per share | 7.97-28.1% | 10.06-18.9% | 10.85-15.0% | 11.17-13.7% | 11.08-16.8% | 12.40-8.6% | 12.77-9.0% | 12.94-11.3% |
| Tangible Book Value Per Share per share | 7.97-28.1% | 10.06-18.9% | 10.85-15.0% | 11.17-13.7% | 11.08-16.8% | 12.40-8.6% | 12.77-9.0% | 12.94-11.3% |
| Full-Time Employees people | 230-1.7% | - | - | - | 234-24.5% | - | - | - |
| Price to Book Ratio ratio | 0.12 | 0.24 | 0.32 | 0.26 | 0.26 | 0.27 | 0.33 | 0.43 |
| Return on Assets % | -13.47 | -9.28 | -7.92 | -7.47 | -8.03 | -5.34 | -4.89 | -5.29 |
| Return on Equity % | -34.96 | -20.57 | -16.75 | -15.93 | -17.98 | -10.25 | -9.27 | -10.06 |
| Return on Invested Capital % | -15.26 | -3.73 | -2.12 | -0.24 | -5.87 | -1.67 | -1.64 | -1.46 |
| Quick Ratio ratio | 0.92 | 0.87 | 0.85 | 1.01 | 1.19 | 1.35 | 1.64 | 1.50 |
| Current Ratio ratio | 1.73 | 1.64 | 1.87 | 1.92 | 2.06 | 2.51 | 2.70 | 2.56 |
Cash flow, quarterly
| Metric | 2026Q46/30/2026 | 2026Q33/31/2026 | 2026Q212/31/2025 | 2026Q19/30/2025 | 2025Q46/30/2025 | 2025Q33/31/2025 | 2025Q212/31/2024 | 2025Q19/30/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -13.54 | -4.31 | -2.55 | -0.29 | -7.22 | -2.19 | -2.19 | -1.98 |
| Depreciation | 1.18+1.7% | 1.19+4.4% | 1.17+3.5% | 1.17+3.5% | 1.16-4.1% | 1.14+3.6% | 1.13-5.0% | 1.13-1.7% |
| Other Funds (Non Cash) | 11.80+175.1% | 1.37+5.4% | 1.59+11.2% | 1.50-45.3% | 4.29+75.8% | 1.30+97.0% | 1.43-49.8% | 2.74+100.0% |
| Funds from Operations | -0.56-130.3% | -1.75-800.0% | 0.20-45.9% | 2.37+25.4% | 1.85 | 0.25+38.9% | 0.37-61.9% | 1.89+3.3% |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -0.51-134.0% | 4.25-26.0% | -6.53 | -6.39 | 1.50 | 5.74 | -0.34 | -5.33-299.6% |
| Income Taxes Payable | 0.07-90.7% | 0.05 | 0.07 | -0.32 | 0.75-65.4% | -0.43 | -1.01 | -0.42 |
| Cash from Operating Activities | -1.07-131.9% | 2.50-58.3% | -6.33-15925.0% | -4.02 | 3.35 | 5.99 | 0.04-88.6% | -3.44-176.4% |
| Capital Expenditures | -0.64 | -1.10 | -0.93 | -1.03 | -1.46 | -0.80 | -1.06 | -0.30 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -0.64 | -1.10 | -0.93 | -1.03 | -1.46 | -0.80 | -1.06 | -0.30 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | -0.00 | -0.08 | 0.00 | -0.01 | -0.00 | -0.17 | 0.00 | -0.01 |
| Repurchase of Common Pref Stock | -0.00 | -0.08 | 0.00 | -0.01 | -0.00 | -0.17 | 0.00 | -0.01 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -0.02 | 4.12 | 3.27 | 0.48-75.1% | -0.17-105.1% | -3.08 | -0.47 | 1.93 |
| Change in Long Term Debt | 2.23 | -0.08 | -0.08 | -0.07 | -0.07 | -0.07 | -0.07 | -0.07 |
| Issuance of Long Term Debt | 11.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -8.77 | -0.08 | -0.08 | -0.07 | -0.07 | -0.07 | -0.07 | -0.07 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | -0.02 | 4.04 | 3.27 | 0.47-75.5% | -0.18-105.4% | -3.24 | -0.47 | 1.92 |
| Net Change in Cash | -1.72-200.6% | 5.44+179.0% | -3.99 | -4.58 | 1.71 | 1.95 | -1.49 | -1.82-157.8% |
| Free Cash Flow | -1.70-189.9% | 1.40-73.0% | -7.26 | -5.05 | 1.89 | 5.19 | -1.02 | -3.74-216.1% |
| Price to Free Cash Flow ratio | - | - | - | 16.99 | 8.74 | - | - | - |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2025 | 2026 | vs 2025 | 2026 share |
|---|---|---|---|---|
| Non-US | 50.73 | 49.19 | -3.0% | 34.5% |
| United States | 79.13 | 93.32 | +17.9% | 65.5% |
| Total | 129.86 | 142.52 | +9.7% | 100.0% |
| Name | 2025 | 2026 | vs 2025 | 2026 share |
|---|---|---|---|---|
| Patent and Trademark Licensing | 8.08 | 7.90 | -2.2% | 5.5% |
| Private Label Contract Manufacturing | 121.78 | 134.62 | +10.5% | 94.5% |
| Total | 129.86 | 142.52 | +9.7% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 0.10% | 0.0M | 5.2M | 41.88K |
| 2026-10-15 | 0.08% | 0.0M | 5.2M | 41.46K |
| 2026-09-30 | 0.13% | 0.0M | 5.2M | 38.33K |
| 2026-09-15 | 0.26% | 0.0M | 5.2M | 42.31K |
| 2026-08-31 | 0.14% | 0.0M | 5.2M | 42.71K |
| 2026-08-14 | 0.48% | 0.0M | 5.2M | 41.37K |
| 2026-07-31 | 0.50% | 0.0M | 5.2M | 20.41K |
| 2026-07-15 | 0.18% | 0.0M | 5.1M | 22.26K |
| 2026-06-30 | 0.13% | 0.0M | 5.1M | 23.07K |
| 2026-06-15 | 0.05% | 0.0M | 5.1M | 22.85K |
| 2026-05-29 | 0.09% | 0.0M | 5.1M | 22.72K |
| 2026-05-15 | 0.03% | 0.0M | 5.1M | 24.32K |
| 2026-04-30 | 0.07% | 0.0M | 5.0M | 25.98K |
| 2026-04-15 | 0.10% | 0.0M | 5.0M | 23.89K |
| 2026-03-31 | 0.22% | 0.0M | 4.9M | 23.59K |
| 2026-03-13 | 0.08% | 0.0M | 4.9M | 18.44K |
| 2026-02-27 | 0.11% | 0.0M | 4.9M | 18.41K |
| 2026-02-13 | 0.03% | 0.0M | 4.9M | 19.19K |
| 2026-01-30 | 0.04% | 0.0M | 4.9M | 21.55K |
| 2026-01-15 | 0.25% | 0.0M | 4.9M | 26.42K |
Option chain
expiry 2026-11-13| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| No option chain for this symbol. | ||||||||||
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-10-23 | DEF 14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | 2026-12-11 | SEC |
| 2026-09-28 | 10-K | Annual report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-05-21 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans | SEC | |
| 2026-05-19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-03-31 | SEC |
| 2026-05-18 | NT 10-Q | 2026-03-31 | SEC | |
| 2026-05-01 | 8-K | Current report | 2026-04-28 | SEC |
| 2026-03-20 | 8-K | Current report | 2026-03-18 | SEC |
| 2026-03-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-03-06 | SEC |
| 2026-03-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-03-06 | SEC |
| 2026-03-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-03-06 | SEC |
| 2026-03-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-03-06 | SEC |
| 2026-03-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-03-06 | SEC |
| 2026-03-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-03-06 | SEC |
| 2026-03-06 | 4 | Statement of changes in beneficial ownership of securities | 2026-03-04 | SEC |
| 2026-03-03 | 4 | Statement of changes in beneficial ownership of securities | 2026-02-27 | SEC |
| 2026-02-27 | 4 | Statement of changes in beneficial ownership of securities | 2026-02-25 | SEC |
| 2026-02-24 | 4 | Statement of changes in beneficial ownership of securities | 2026-02-20 | SEC |
| 2026-02-20 | 4 | Statement of changes in beneficial ownership of securities | 2026-02-17 | SEC |
| 2026-02-13 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2025-12-31 | SEC |
| 2026-01-21 | SCHEDULE 13G/A | SEC | ||
| 2026-01-05 | 4 | Statement of changes in beneficial ownership of securities | 2025-12-23 | SEC |
| 2025-12-17 | 8-K | Current report | 2025-12-17 | SEC |
| 2025-12-12 | 8-K | Current report | 2025-12-05 | SEC |
| 2025-11-12 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2025-09-30 | SEC |
| 2025-10-23 | DEF 14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | 2025-12-05 | SEC |
| 2025-09-23 | 10-K | Annual report pursuant to Section 13 or 15(d) | 2025-06-30 | SEC |
| 2025-07-21 | 8-K | Current report | 2025-07-16 | SEC |
| 2025-07-01 | 8-K | Current report | 2025-06-27 | SEC |
| 2025-06-23 | 8-K | Current report | 2025-06-20 | SEC |
| 2025-05-14 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2025-03-31 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 4.87K | 4 | 0 | 0 |
| 2026-02 | 21.96K | 10 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| CALDWELL SUTTER CAPITAL, INC. | 7.94% |
| DIMENSIONAL FUND ADVISORS LP | 5.35% |
| MORGAN STANLEY | 4.90% |
| Mink Brook Asset Management LLC | 4.68% |
| RENAISSANCE TECHNOLOGIES LLC | 4.08% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.36% |
| CITADEL ADVISORS LLC | 1.21% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.98% |
| Integrated Wealth Concepts LLC | 0.70% |
| GEODE CAPITAL MANAGEMENT, LLC | 0.68% |
Funds
| Fund | % owned |
|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 2.53% |
| U.S. SMALL CAP VALUE PORTFOLIO | 2.26% |
| U.S. MICRO CAP PORTFOLIO | 1.07% |
| VANGUARD EXTENDED MARKET INDEX FUND | 0.83% |
| U.S. SMALL CAP PORTFOLIO | 0.41% |
| EA Bridgeway Omni Small-Cap Value ETF | 0.40% |
| Fidelity Extended Market Index Fund | 0.33% |
| Omni Small-Cap Value Fund | 0.29% |
| Ultra-Small Company Market Fund | 0.28% |
| Dimensional U.S. Small Cap ETF | 0.27% |
OakChart. NAII. Cached 15 minutes. Terms
Some panels did not load: ratings.